Corvus Pharmaceuticals, Inc. (CRVS) Ownership

$6.03

north_east
$0.2 (3.43%)
Day's range
$5.83
Day's range
$6.47

Corvus Pharmaceuticals, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
ORBIMED ADVISORS LLC 02/14/2025 6.94 M $37.15 M   0.00% 10.41%
SAMLYN CAPITAL, LLC 02/14/2025 6.67 M $35.67 M   47.17% 10.00%
ADAMS STREET PARTNERS LLC 02/14/2025 3.28 M $17.52 M   0.00% 4.91%
POINT72 ASSET MANAGEMENT, L.P. 02/14/2025 3.03 M $16.21 M   -45.53% 4.54%
RTW INVESTMENTS, LP 02/14/2025 2.68 M $14.34 M   100.00% 4.02%
VANGUARD GROUP INC 02/11/2025 2.45 M $13.13 M   1.40% 3.68%
VIVO CAPITAL, LLC 02/13/2025 2.23 M $11.95 M   49.24% 3.35%
FORESITE CAPITAL MANAGEMENT VI LLC 02/14/2025 1.58 M $8.46 M   100.00% 2.37%
BLACKROCK FUNDING, INC. /DE 02/07/2025 1.07 M $5.74 M   77.68% 1.61%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 1.02 M $5.43 M   363.59% 1.52%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 02/14/2025 1.00 M $5.35 M   100.00% 1.50%
IKARIAN CAPITAL, LLC 02/14/2025 754,400 $4.04 M   245.58% 1.13%
CAPTION MANAGEMENT, LLC 02/14/2025 631,200 $3.38 M   100.00% 0.95%
GOLDMAN SACHS GROUP INC 02/11/2025 584,546 $3.13 M   55.41% 0.88%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 566,863 $3.03 M   0.68% 0.85%
SPHERA FUNDS MANAGEMENT LTD. 02/14/2025 500,491 $2.68 M   100.00% 0.75%
GOLDMAN SACHS GROUP INC 02/11/2025 500,000 $2.68 M   0.00% 0.75%
IKARIAN CAPITAL, LLC 02/14/2025 500,000 $2.68 M   100.00% 0.75%
QUBE RESEARCH & TECHNOLOGIES LTD 02/14/2025 450,050 $2.41 M   253.45% 0.67%
RENAISSANCE TECHNOLOGIES LLC 02/13/2025 390,688 $2.09 M   1.06% 0.59%
BOOTHBAY FUND MANAGEMENT, LLC 02/14/2025 218,600 $1.17 M   242.63% 0.33%
STATE STREET CORP 02/14/2025 205,538 $1.10 M   15.31% 0.31%
MILLENNIUM MANAGEMENT LLC 02/14/2025 181,200 $969,420   18.59% 0.27%
JANE STREET GROUP, LLC 02/14/2025 162,300 $868,305   100.00% 0.24%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 159,200 $851,720   323.40% 0.24%
MILLENNIUM MANAGEMENT LLC 02/14/2025 154,901 $828,720   -50.24% 0.23%
LMR PARTNERS LLP 02/14/2025 152,500 $815,875   100.00% 0.23%
BOOTHBAY FUND MANAGEMENT, LLC 02/14/2025 144,300 $772,005   100.00% 0.22%
SIMPLEX TRADING, LLC 02/11/2025 139,933 $748,000   2,367.95% 0.21%
SCHONFELD STRATEGIC ADVISORS LLC 02/14/2025 129,076 $690,556   -61.05% 0.19%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 124,300 $665,005   179.96% 0.19%
ENTRYPOINT CAPITAL, LLC 02/11/2025 116,645 $624,051   100.00% 0.17%
JANE STREET GROUP, LLC 02/14/2025 114,952 $614,993   128.89% 0.17%
RAYMOND JAMES FINANCIAL INC 02/13/2025 108,989 $583,092   100.00% 0.16%
BARCLAYS PLC 02/13/2025 106,019 $567,000   100.00% 0.16%
SQUAREPOINT OPS LLC 02/14/2025 98,144 $525,070   712.45% 0.15%
ENGINEERS GATE MANAGER LP 02/14/2025 84,612 $452,674   100.00% 0.13%
TOWERVIEW LLC 02/05/2025 77,500 $414,625   -34.04% 0.12%
OMERS ADMINISTRATION CORP 02/14/2025 75,500 $403,925   100.00% 0.11%
ACUTA CAPITAL PARTNERS, LLC 02/14/2025 74,307 $397,542   100.00% 0.11%
JANE STREET GROUP, LLC 02/14/2025 69,200 $370,220   100.00% 0.10%
JACKSON SQUARE CAPITAL, LLC 01/15/2025 63,773 $341,186   0.00% 0.10%
XTX TOPCO LTD 02/13/2025 57,213 $306,090   306.17% 0.09%
GROUP ONE TRADING, L.P. 02/14/2025 52,768 $282,309   849.06% 0.08%
UBS GROUP AG 02/14/2025 52,109 $278,783   232.31% 0.08%
HIKARI POWER LTD 02/04/2025 49,959 $267,000   0.00% 0.07%
BALYASNY ASSET MANAGEMENT L.P. 02/14/2025 48,335 $258,592   100.00% 0.07%
CITIGROUP INC 02/12/2025 48,222 $257,988   -60.75% 0.07%
AMERICAN CENTURY COMPANIES INC 02/11/2025 43,774 $234,191   140.41% 0.07%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 02/14/2025 41,300 $220,955   -67.56% 0.06%

Corvus Pharmaceuticals, Inc. institutional Ownership - FAQ's

During the previous two years, 109 institutional investors and hedge funds held shares of Corvus Pharmaceuticals, Inc.. The most heavily invested institutionals were:

ORBIMED ADVISORS LLC: 6.94 M

SAMLYN CAPITAL, LLC: 6.67 M

ADAMS STREET PARTNERS LLC: 3.28 M

Point72 Asset Management, L.P.: 3.03 M

RTW INVESTMENTS, LP: 2.68 M

VANGUARD GROUP INC: 2.45 M

56.48% of Corvus Pharmaceuticals, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 40.33 M shares in the last 24 months. This purchase volume represents approximately $243.20 M in transactions.